{
    "body": "Is protein CXCR4 used as a prognostic marker of cancer?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20061818", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23822165", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23650783", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22473623", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21234386", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22075627", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24650104", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23213054", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23359227", 
        "http://www.ncbi.nlm.nih.gov/pubmed/26221287", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23936528", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23395387"
    ], 
    "ideal_answer": [
        "Yes, the chemokine C-X-C motif receptor 4 (CXCR4) has been found to be a prognostic marker in various types of cancer."
    ], 
    "exact_answer": "yes", 
    "type": "yesno", 
    "id": "56e68967edfc094c1f000002", 
    "snippets": [
        {
            "offsetInBeginSection": 1568, 
            "offsetInEndSection": 1722, 
            "text": "Aberrant overexpression of CXCR4 is associated with worse overall survival, adenocarcinoma histology, distant metastasis, lymph node involvement in NSCLC.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/26221287", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 177, 
            "text": "CXCR4 belongs to a family of G protein-coupled cell surface receptors and has been proved to a prognostic marker in a various tumors, including esophageal squamous cell cancer. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23822165", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 664, 
            "offsetInEndSection": 838, 
            "text": "The chemokine C-X-C motif receptor 4 (CXCR4) has been found to be a prognostic marker in various types of cancer, being involved in chemotaxis, stemness and drug resistance. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24650104", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 862, 
            "offsetInEndSection": 1138, 
            "text": "The chemokine receptor CXCR4 that has been shown to be implicated in PDAC tumorigenicity and aggressiveness could serve as a prognostic marker for survival after a curative-intent surgery and was associated with the pattern of tumour recurrence (distant versus local relapse).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23650783", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 197, 
            "offsetInEndSection": 322, 
            "text": "XCR4 promotes tumor growth, angiogenesis and metastasis, and is a prognostic marker in a number of different types of tumors.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23395387", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 9, 
            "offsetInEndSection": 115, 
            "text": "CXCR4 has been identified as a prognostic marker for acute myeloid leukemia (AML) and other malignancies. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23213054", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 196, 
            "offsetInEndSection": 319, 
            "text": "The chemokine receptor CXCR4 has been found to be a prognostic marker in various types of cancer, including breast cancer. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23359227", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 125, 
            "text": "Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23936528", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1662, 
            "offsetInEndSection": 1766, 
            "text": "detection of CXCR4 expression will be helpful for predicting prognosis for patients with gastric cancer.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23936528", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 206, 
            "offsetInEndSection": 269, 
            "text": "The chemokine receptor CXCR4 is a marker of metastatic disease.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22473623", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1475, 
            "offsetInEndSection": 1596, 
            "text": "High CXCR4 level in cancer specimens independently predicts a poor outcome for patients with node-positive breast cancer.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22473623", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 953, 
            "offsetInEndSection": 1190, 
            "text": "Univariate and multivariate analyses demonstrated that the high levels of nuclear CXCR4 and CXCL12 expression in hepatocytes were significantly better prognostic factors for overall and hepatic disease-free survival in patients with CLM.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22075627", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 163, 
            "offsetInEndSection": 307, 
            "text": "The chemokine receptor CXCR4 has been implicated in sarcoma development and has been found to be a prognostic marker for poor clinical outcome. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21234386", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1598, 
            "offsetInEndSection": 1756, 
            "text": "high CXCR4 expression is correlated to shorter DFS and could be used as a prognostic marker in order to stratify melanoma patients at higher progression risk.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20061818", 
            "endSection": "abstract"
        }
    ]
}